164 related articles for article (PubMed ID: 35150157)
1. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
Adriaansen BPH; Kamphuis JS; Schröder MAM; Olthaar AJ; Bock C; Brandt A; Stikkelbroeck NMML; Lentjes EGWM; Span PN; Sweep FCGJ; Claahsen-van der Grinten HL; van Herwaarden AE
Clin Endocrinol (Oxf); 2022 Jul; 97(1):36-42. PubMed ID: 35150157
[TBL] [Abstract][Full Text] [Related]
2. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
[TBL] [Abstract][Full Text] [Related]
3. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
[TBL] [Abstract][Full Text] [Related]
4. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.
Nowotny HF; Auer MK; Lottspeich C; Schmidt H; Dubinski I; Bidlingmaier M; Adaway J; Hawley J; Keevil B; Reisch N
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4509-e4519. PubMed ID: 34165575
[TBL] [Abstract][Full Text] [Related]
5. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
[TBL] [Abstract][Full Text] [Related]
6. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: reference ranges throughout childhood and adolescence.
Dressendorfer RA; Strasburger CJ; Bidlingmaier F; Klug I; Kistner A; Siebler T; Kiess W
Pediatr Res; 1998 Nov; 44(5):650-5. PubMed ID: 9803445
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
Bacila I; Adaway J; Hawley J; Mahdi S; Krone R; Patel L; Alvi S; Randell T; Gevers E; Dattani M; Cheetham T; Kyriakou A; Schiffer L; Ryan F; Crowne E; Davies JH; Ahmed SF; Keevil B; Krone N
J Clin Endocrinol Metab; 2019 Dec; 104(12):6417-6429. PubMed ID: 31361321
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
9. Diurnal 11-ketotestosterone and 17-hydroxyprogesterone saliva profiles in paediatric classical congenital adrenal hyperplasia.
Dubinski I; Bechtold-Dalla Pozza S; Bidlingmaier M; Hawley J; Keevil B; Kunz S; Nowotny HF; Reisch N; Schiergens K; Tschaidse L; Schmidt H
J Pediatr Endocrinol Metab; 2024 May; 37(5):419-424. PubMed ID: 38557593
[TBL] [Abstract][Full Text] [Related]
10. Salivary 17-Hydroxyprogesterone Levels in Children with Congenital Adrenal Hyperplasia: A Retrospective Longitudinal Study Considering Auxological Parameters.
Dubinski I; Bechtold S; Bidlingmaier M; Reisch N; Schmidt H
Horm Res Paediatr; 2023; 96(3):259-266. PubMed ID: 35960318
[TBL] [Abstract][Full Text] [Related]
11. A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
Besci Ö; Erbaş İM; Küme T; Acinikli KY; Abacı A; Böber E; Demir K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):145-152. PubMed ID: 34866371
[TBL] [Abstract][Full Text] [Related]
12. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.
Schröder MAM; van Herwaarden AE; Span PN; van den Akker ELT; Bocca G; Hannema SE; van der Kamp HJ; de Kort SWK; Mooij CF; Schott DA; Straetemans S; van Tellingen V; van der Velden JA; Sweep FCGJ; Claahsen-van der Grinten HL
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1661-e1672. PubMed ID: 34788830
[TBL] [Abstract][Full Text] [Related]
14. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.
de Groot MJ; Pijnenburg-Kleizen KJ; Thomas CM; Sweep FC; Stikkelbroeck NM; Otten BJ; Claahsen-van der Grinten HL
Clin Chem Lab Med; 2015 Feb; 53(3):461-8. PubMed ID: 25283138
[TBL] [Abstract][Full Text] [Related]
15. Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling.
Mezzullo M; Fazzini A; Gambineri A; Di Dalmazi G; Mazza R; Pelusi C; Vicennati V; Pasquali R; Pagotto U; Fanelli F
Clin Chem Lab Med; 2017 Aug; 55(9):1315-1323. PubMed ID: 28076306
[TBL] [Abstract][Full Text] [Related]
16. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
Feng D; Wang Z; Li H; Shi X; Zou L; Kong H; Xu Z; Yu C; Hu C; Xu G
Clin Chim Acta; 2023 Mar; 543():117304. PubMed ID: 36958425
[TBL] [Abstract][Full Text] [Related]
17. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
Hoepffner W; Hubl W
Exp Clin Endocrinol; 1986 Jul; 87(2):189-94. PubMed ID: 3530788
[TBL] [Abstract][Full Text] [Related]
18. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
[TBL] [Abstract][Full Text] [Related]
19. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
[TBL] [Abstract][Full Text] [Related]
20. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
